Background and Aims: The prognosis of patients with gastric cancer is poor, even following
histologically proven primary gastric adenocarcinomas were analyzed. At laparotomy the abdomen was irrigated with 200 ml of normal saline, and ≥50 ml were aspirated and examined by means of cytology and immunocytopathology.
Results: PLC was positive in 7 cases (11%). Overall, 86% of patients with a positive PLC had a pT3/pT4 tumor and 100% with a positive PLC had a N-positive tumor (p<0.001); 71% of patients with a positive PLC had a grade G3/G4 tumor (p=0.001). At a median follow up of 32 months, the cumulative 5-year survival was 28%. The median survival of patients presenting positive PLC (19 months) was significantly lower than that of patients with negative peritoneal cytology (38 months) (p=0.0001). Multivariate analysis identified cytology as a significant predictor of outcome (p=0.018).
Conclusions:
Results in the present series demonstrated that patients with a positive peritoneal cytology had advanced disease and poor prognosis, thus indicating that patients with locally advanced gastric cancer should undergo staging laparoscopy and PLC examination in order to select those requiring more aggressive treatment.
Future therapeutic strategies should include PLC examination in preoperative staging, in order to select patients for more aggressive treatment.
Introduction
Gastric cancer is the third most frequent cause of cancer death in Western countries 1 . Prognosis of these patients is poor, with a cumulative 5-year survival rate of 20%, and this is primarily related to the extent of disease at presentation. Even after R0 resections, approximately 50% of patients die from recurrent disease within the first 2 years of follow-up 2, 3 . The most frequent site of recurrence following R0 resection is the peritoneum 4, 5 , probably due to the intraperitoneal presence of free cancer cells shed from the serosal surface of the primary tumor 6 . The majority of patients with intraperitoneal free cancer cells (IFCCs) do not escape postoperative peritoneal recurrence [7] [8] [9] .
Clinical studies [6] [7] [8] have shown that peritoneal cytology findings are an independent prognostic factor in gastric cancer and, indeed, the Japanese Research Society for Gastric Cancer has now included peritoneal cytology as part of the staging process in gastric cancer 10 .
In this report findings are presented related to a series of 64 patients who underwent laparotomy and Tumor grading was as follows: G1 7%, G2 33%, G3 51%, G4 9%.
Of 64 patients, 27 (42%) underwent postoperative chemotherapy.
All patients were followed for at least one year or until death. At the time of the present evaluation, the median follow-up time of surviving patients was 32 months (range 12 -56).
Peritoneal washing
Upon entering the abdominal cavity, prior to manipulating the tumor, 200 ml of warm normal saline were introduced and manually dispersed in the Douglas cavity, para-colic gutters and in the right and left subphrenic cavity. At least 50 ml of fluid was subsequently recovered, after gentle stirring, from several regions of the abdominal cavity. The fluid was then centrifuged for 5 min at 1500 rpm.
The sediment was smeared onto one or more glass slides and stained using the Papanicolau's method. All cytological examinations were performed by experienced cytopathologists. Cytological findings were classified as positive, negative or suspicious. The following cell characteristics were used to determine the presence of malignant cells: presence of aggregate, size, shape, type of cytoplasm, cytoplasmic vacuoli, mainly nuclear abnormalities, nuclear chromatin, nuclearcytoplasmic ratio, mitotic figures, and nucleolar prominence.
When necessary, the glass slide containing the nucleated cell layer was analyzed at immunocytochemistry (ICC) using the CEA antigen antibodies (monoclonal CEA clone 11-7 Dako ® ). The glass slide was decolorized using 95% alcohol and 1% of chlorhydric acid, and then treated with CEA antibodies. ICC was performed in 20 suspicious cases.
Statistics
Statistical analyses were performed using MedCalc for Windows, version 10.2.0.0 (MedCalc Software, MariaKerke, Belgium). Differences in distribution were calculated using the chi-square M A N U S C R I P T
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5 test or Fisher's exact test depending on the number of cases in each subgroup. Survival was estimated using Kaplan-Meier's method, and differences were assessed by means of the log-rank test 11, 12 . Overall survival was defined as the time interval between surgery and death, regardless of the cause.
p<0.1 was used as the cut-off value for statistical significance in the variable selection in the multivariate modelling in order not to overlook any potentially important predictors. Only those variables significant at univariate analysis were included in the model. Statistical significance remained conventionally defined as p<0.05 in all other cases.
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Results
Of the 64 tumors, 7 (11%) showed a positive cytology.
PLC was significantly related to the pathological findings (Table I) . Overall 86% of patients with a positive PLC had a pT3/pT4 tumor and 100% of the patients with a positive PLC had a N-positive tumor (p<0.001); in 71% of patients with a positive PLC, the tumor grade was G3/G4 (p=0.001).
These results indicate that the rate of positive peritoneal wash samples increases proportionally when the tumor invades the deeper layers of the gastric wall or the lymph nodes, and when the tumor has lost differentiation.
At a median follow-up of 32 months, the cumulative 5-year survival rate was 28%. The median overall survival in patients with a positive PLC was significantly lower than that in patients with a negative PLC (19 vs 38 months; p=0.0001) (Figure 1 ). In the univariate analysis, the extent of the tumor (pT), patient sex and lymph node involvement were also found to be significant predictors of survival, while the tumor grading and age of the patients were not. When these variables were included in a multivariate model, only cytology and the extent of the tumor remained significant independent predictors of survival (Table II) .
In a subgroup analysis of pT3/pT4 tumors, patients with a negative PLC lived longer than those . In patients with serosa involvement, peritoneal recurrence reaches 50% even if curative resections are performed 14, 15 . Peritoneal recurrence develops from peritoneal free cancer cells originating from the primary lesion or metastatic lymph nodes [16] [17] [18] . It has been shown that patients with a gastric tumor involving the serosa or the lymph nodes have a high probability of producing peritoneal free cancer cells and developing peritoneal recurrence or carcinomatosis [5] [6] [7] [8] [9] [10] .
Data in the literature show a significant difference, in terms of survival, between patients with a positive peritoneal cytology and those with negative findings, thus indicating that positive peritoneal cytology is an important prognostic factor. In fact, since 1998, the Japanese Gastric
Cancer Association (JGCA) has suggested that the presence of free cancer cells in the peritoneal cavity, should be considered as an independent prognostic marker in patients with gastric cancer In the present study, the median overall survival in patients with positive PLC was significantly lower than that in patients with negative PLC (19 vs 38 months; p=0.008), and cytology was a significant prognostic marker both at the univariate and multivariate analysis.
PLC is widely accepted as the gold standard for diagnosis of IFCCs. Cytology is easy and safe to perform, it takes approximately 15 min for a cytopathologist to analyze the patient's slides, and the estimated cost for this procedure is $ 60 20 . The rate of detection of IFCC in the literature ranges from 14%-47%, depending upon the cohort of patients studied 21 . When only potentially curative resections are included, the rate of IFCC varies from 4.4%-11%, and ranges from 22%-30% in gastric carcinoma involving the serosa [22] [23] [24] . In our experience, cytology was positive in 11% of the entire population studied and in 25% of patients with a pT3/pT4 tumor.
In agreement with Koga et al. 6 , we found positive peritoneal cytology in 1/30 (2.5%) pT2 tumors.
This finding may depend upon one of 2 conditions, namely: the histological examination of the depth of invasion may not always be performed at a spot where the cancer infiltration is deepest, resulting in pT downstaging or, the cancer cells could be shed through the lymphatics, from the metastatic lymph nodes or through the lymphatic canals via the omentum 20 . In our series, in fact, the patient with positive cytology and a pT2 tumor presented a N1 status at the final histopathological examination.
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8 Although IFCCs are detected in a considerable number of gastric cancer patients, the probability of peritoneal recurrence far exceeds the rate of IFCC detected 14, 15 . Patients presenting progressive disease, during neoadjuvant treatment, may be spared laparotomy.
A prospective study is now mandatory in order to assess the efficacy of this alternative treatment in prolonging survival in patients with locally advanced disease.
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